$HIMS

Hims & Hers Health, Inc.

CIK:0001773751|SEC Filings
v3.25.4
Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Revenue $ 2,347,637 $ 1,476,514 $ 872,000
Cost of revenue 614,259 303,379 157,051
Gross profit 1,733,378 1,173,135 714,949
Operating expenses:      
Marketing 919,296 678,844 446,435
Operations and support 286,444 185,802 119,857
Technology and development 149,301 78,819 48,227
General and administrative 272,724 167,767 129,883
Total operating expenses 1,627,765 1,111,232 744,402
Income (loss) from operations 105,613 61,903 (29,453)
Other income (expense):      
Change in fair value of equity securities 4,437 0 0
Change in fair value of liabilities (9,255) 0 (1,075)
Other income, net 23,129 9,808 8,957
Total other income, net 18,311 9,808 7,882
Income (loss) before income taxes 123,924 71,711 (21,571)
Benefit from (provision for) income taxes 4,441 54,327 (1,975)
Net income (loss) 128,365 126,038 (23,546)
Other comprehensive income (loss) 2,618 (200) 153
Total comprehensive income (loss) $ 130,983 $ 125,838 $ (23,393)
Net income (loss) per share attributable to common stockholders, Class A and Class V:      
Basic (in USD per share) $ 0.57 $ 0.58 $ (0.11)
Diluted (in USD per share) $ 0.51 $ 0.53 $ (0.11)
Weighted average shares outstanding, Class A and Class V:      
Basic (in shares) 224,959,268 215,939,037 209,344,712
Diluted (in shares) 258,230,547 236,808,876 209,344,712